Intratympanic plus systemic corticosteroids (combined therapy) vs systemic corticosteroids alone: Change in hearing threshold determined by PTA Range 0 dB to 140 dB Negative values represent lowering and positive values represent raising of the hearing threshold. A lower hearing threshold represents hearing improvement. Â
- Population
- sudden sensorineural hearing loss
- Intervention
- Intratympanic plus systemic corticosteroids (combined therapy)
- Comparison
- systemic corticosteroids alone
- Outcome
- Change in hearing threshold determined by PTA Range 0 dB to 140 dB Negative values represent lowering and positive values represent raising of the hearing threshold. A lower hearing threshold represents hearing improvement. Â
Intratympanic plus systemic corticosteroids (combined therapy) showed no clear difference in change in hearing threshold determined by PTA Range 0 dB to 140 dB… compared with systemic corticosteroids alone (low certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intratympanic plus systemic corticosteroids (combined therapy) vs systemic corticosteroids alone Change in hearing threshold determined by PTA Range 0 dB to 140 dB Negative values represent lowering and positive values represent raising of the hearing threshold. A lower hearing threshold represents hearing improvement. Â · sudden sensorineural hearing loss Intratympanic plus systemic corticosteroids (combined therapy) showed no clear difference in change in hearing threshold determined by PTA Range 0 dB to 140 dB… compared with systemic corticosteroids alone (low certainty). Intratympanic corticosteroids for sudden sensorineural hearing loss (2022) · Cochrane Headline outcomes only | no estimate extracted | 6 studies · 435 participants | Low |
Intratympanic plus systemic corticosteroids (combined therapy) vs systemic corticosteroids alone Change in hearing threshold determined by PTA · sudden sensorineural hearing loss The review found no eligible studies for this question. Intratympanic corticosteroids for sudden sensorineural hearing loss (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.